Immunoprecipitation Market by Product (Kit, Reagent (Antibodies, Magnetic Buffer)), Type (Individual IP, Coimmunoprecipitation, CHIP), End User (Academics, Research Institutes, Pharmaceutical and Biotechnology Companies)

Increasing research activity in the life sciences industry is expected to drive the overall growth of the immunoprecipitation market.

The immunoprecipitation market is projected to reach USD 750 million by 2024 from USD 560 million in 2018, at CAGR of 5.0% during forecast period. The growth of this market is majorly driven by the increasing number of research activities in the life sciences industry and the growing need to identify antigens associated with autoimmune diseases (through antigen-antibody interaction to understand disease mechanisms and develop relevant drugs targeting these diseases). However, the presence of alternative technologies for protein purification is expected to restrain the growth of this market in the coming years.

The kits segment is expected to grow at the highest CAGR during the forecast period.

The immunoprecipitation market, by product, has been categorized into three major segments - kits, reagents, and accessories. The kits segment is estimated to grow at the highest CAGR from 2018 to 2024. The need for repeat purchase of kits, coupled with the increasing number of IP assays to isolate and purify antigens, forms a major driver for the growth of this segment.

The pharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR during the forecast period.

The immunoprecipitation market, by end user, has been categorized into three major segments - academic & research institutes, pharmaceutical & biotechnology companies, and contract research organizations (CROs). The pharmaceutical & biotechnology companies segment is estimated to grow at the highest CAGR from 2018 to 2024. The increasing demand for protein-based drugs to drive the demand for immunoprecipitation in this end-user segment will support market growth.

Asia Pacific projected to grow at the highest CAGR during the forecast period.

In the immunoprecipitation market, Asia Pacific is projected to record the highest growth during the forecast period. China, Japan, and India are the major markets for immunoprecipitation in the Asia Pacific. Increasing investments by governments and industries, growing biotechnology research in these regions, and rising awareness about personalized therapeutics are expected to drive the growth of these markets during the forecast period.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the immunoprecipitation market.

By Company Type: Tier 1–48%, Tier 2–34%, and Tier 3–18%
By Designation: C-level Executives–42%, Directors–40%, and Others–18%
By Region: North America–38%, Europe–25%, APAC–30%, and RoW–7%

The immunoprecipitation market comprises major providers such as Thermo Fisher Scientific (US), Abcam (UK), Merck KGaA (Germany). The study includes an in-depth competitive analysis of these key players in the immunoprecipitation market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:
The market study covers the immunoprecipitation market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, on the basis of product, analyte type, product, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall immunoprecipitation market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.

1 Introduction

1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders
1.6 Limitations

2 Research Methodology

2.1 Research Approach
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Break Down of Primaries
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights

4.1 Immunoprecipitation: Market Overview
4.2 Immunoprecipitation Market, By Product (2018–2024)
4.3 North America: Immunoprecipitation Market, By Type (2018)

5 Market Overview

5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Number of Life Sciences Research Activities
5.2.1.2 Growing Need to Identify Antigens That are Associated With Autoimmune Diseases
5.2.2 Restraints
5.2.2.1 Presence of Alternative Technologies
5.2.3 Opportunities
5.2.3.1 Increasing Focus on Biomarker Discovery
5.2.4 Challenges
5.2.4.1 Quality Concerns Over Research Antibodies

6 Immunoprecipitation Market, By Type

6.1 Introduction
6.2 Individual Immunoprecipitation
6.2.1 Increasing Demand for Biologics is Driving the Growth of the Market
6.3 Co-Immunoprecipitation
6.3.1 Increasing Use of Co-Ip to Study Protein Complexes Forms A Key Market Driver
6.4 Chromatin Immunoprecipitation
6.4.1 Growing Adoption of High-Throughput Technologies Will Contribute to Adoption of Chip
6.5 Rna Immunoprecipitation
6.5.1 Availability of Government Funding Will Drive the Adoption of Rip Kits

7 Immunoprecipitation Market, By Product

7.1 Introduction
7.2 Kits
7.2.1 Kits Segment to Account for the Largest Share of the Immunoprecipitation Market During the Forecast Period
7.3 Reagents
7.3.1 Antibodies
7.3.1.1 Antibodies, By Type
7.3.1.1.1 Primary Antibodies
7.3.1.1.1.1 Primary Antibodies to Account for the Largest Share of the Immunoprecipitation Antibodies Market During the Forecast Period
7.3.1.1.2 Secondary Antibodies
7.3.1.1.2.1 Low Cost of Production - A Major Factor Driving the Growth of the Secondary Antibodies Market
7.3.2 Beads
7.3.2.1 Beads, By Type
7.3.2.2 Agarose Beads
7.3.2.2.1 High Binding Capacity and Lower Cost – Factors Supporting the Wide Use of Agarose Beads in Research Laboratories
7.3.2.3 Magnetic Beads
7.3.2.3.1 Magnetic Bead-Based Separation Helps Increase Throughput and Reduces Hands-On Time
7.3.2.4 Buffers
7.3.2.4.1 Buffer Solutions Play an Important Role in Maintaining Ph Balance in Ip Assays
7.4 Accessories

8 Immunoprecipitation Market, By End User

8.1 Introduction
8.2 Academic & Research Institutes
8.2.1 Academic & Research Institutes are the Largest End Users of Immunoprecipitation
8.3 Pharmaceutical & Biotechnology Companies
8.3.1 Increasing Demand for Protein-Based Drugs to Drive the Demand for Immunoprecipitation in This End-User Segment
8.4 Contract Research Organizations
8.4.1 Growth in Outsourcing of Protein Purification Activities - A Major Factor Driving the Demand for Immunoprecipitation Technologies in Contract Research Organizations

9 Immunoprecipitation Market, By Region

9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Growing Research Will Drive Market Growth
9.2.2 Canada
9.2.2.1 Increasing Genomics and Proteomics Research to Drive the Adoption of Immunoprecipitation in the Coming Years
9.3 Europe
9.3.1 Growth of the Life Sciences Sector Will Support the Demand for Immunoprecipitation
9.4 Asia Pacific
9.4.1 Increasing Demand for Novel Antibody and Protein-Based Drugs Support Market Growth in the Asia Pacific
9.5 Rest of the World

10 Competitive Landscape

10.1 Overview
10.2 Vendor Benchmarking
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Market Ranking Analysis, 2017
10.5 Competitive Situation and Trends
10.5.1 Expansions
10.5.2 Collaborations, Partnerships, and Agreements
10.5.3 Product Launches
10.5.4 Acquisitions

11 Company Profiles

11.1 Thermo Fisher Scientific
11.2 Abcam
11.3 Genscript
11.4 Merck KGaA
11.5 Bio-Rad Laboratories
11.6 Biolegend
11.7 Takara Bio
11.8 Rockland Immunochemicals
11.9 Cell Signaling Technology
11.10 Geno Technology

12 Appendix

12.1 Discussion Guide
12.2 Knowledge Store: Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details

List of Tables

Table 1 Immunoprecipitation Market, By Type, 2016–2024 (USD Million)
Table 2 Individual Immunoprecipitation Market, By Region, 2016–2024 (USD Million)
Table 3 North America: Individual Immunoprecipitation Market, By Country, 2016–2024 (USD Million)
Table 4 Co-Immunoprecipitation Market, By Region, 2016–2024 (USD Million)
Table 5 North America: Co-Immunoprecipitation Market, By Country, 2016–2024 (USD Million)
Table 6 Chromatin Immunoprecipitation Market, By Region, 2016–2024 (USD Million)
Table 7 North America: Chromatin Immunoprecipitation Market, By Country, 2016–2024 (USD Million)
Table 8 Rna Immunoprecipitation Market, By Region, 2016–2024 (USD Million)
Table 9 North America: Rna Immunoprecipitation Market, By Country, 2016–2024 (USD Million)
Table 10 Immunoprecipitation Market, By Product, 2016–2024 (USD Million)
Table 11 Immunoprecipitation Kits Market, By Region, 2016–2024 (USD Million)
Table 12 North America: Immunoprecipitation Kits Market, By Country, 2016–2024 (USD Million)
Table 13 Immunoprecipitation Reagents Market, By Region, 2016–2024 (USD Million)
Table 14 North America: Immunoprecipitation Reagents Market, By Country, 2016–2024 (USD Million)
Table 15 Immunoprecipitation Reagents Market, By Type, 2016–2024 (USD Million)
Table 16 Immunoprecipitation Antibodies Market, By Region, 2016–2024 (USD Million)
Table 17 North America: Immunoprecipitation Antibodies Market, By Country, 2016–2024 (USD Million)
Table 18 Immunoprecipitation Antibodies Market, By Type, 2016–2024 (USD Million)
Table 19 Immunoprecipitation Market for Primary Antibodies, By Region, 2016–2024 (USD Million)
Table 20 North America: Immunoprecipitation Market for Primary Antibodies, By Country, 2016–2024 (USD Million)
Table 21 Immunoprecipitation Market for Secondary Antibodies, By Region, 2016–2024 (USD Million)
Table 22 North America: Immunoprecipitation Market for Secondary Antibodies, By Country, 2016–2024 (USD Million)
Table 23 Immunoprecipitation Beads Market, By Region, 2016–2024 (USD Million)
Table 24 North America: Immunoprecipitation Beads Market, By Country, 2016–2024 (USD Million)
Table 25 Immunoprecipitation Beads Market, By Type, 2016–2024 (USD Million)
Table 26 Immunoprecipitation Market for Agarose Beads, By Region, 2016–2024 (USD Million)
Table 27 North America: Immunoprecipitation Market for Agarose Beads, By Country, 2016–2024 (USD Million)
Table 28 Immunoprecipitation Market for Magnetic Beads, By Region, 2016–2024 (USD Million)
Table 29 North America: Immunoprecipitation Market for Magnetic Beads, By Country, 2016–2024 (USD Million)
Table 30 Immunoprecipitation Buffers Market, By Region, 2016–2024 (USD Million)
Table 31 North America: Immunoprecipitation Buffers Market, By Country, 2016–2024 (USD Million)
Table 32 Immunoprecipitation Accessories Market, By Region, 2016–2024 (USD Million)
Table 33 North America: Immunoprecipitation Accessories Market, By Country, 2016–2024 (USD Million)
Table 34 Immunoprecipitation Market, By End User, 2016–2024 (USD Million)
Table 35 Immunoprecipitation Market for Academic & Research Institutes, By Region, 2016–2024 (USD Million)
Table 36 North America: Immunoprecipitation Market for Academic & Research Institutes, By Country, 2016–2024 (USD Million)
Table 37 Immunoprecipitation Market for Pharmaceutical & Biotechnology Companies, By Region, 2016–2024 (USD Million)
Table 38 North America: Immunoprecipitation Market for Pharmaceutical & Biotechnology Companies, By Country, 2016–2024 (USD Million)
Table 39 Immunoprecipitation Market for Contract Research Organizations, By Region, 2016–2024 (USD Million)
Table 40 North America: Immunoprecipitation Market for Contract Research Organizations, By Country, 2016–2024 (USD Million)
Table 41 Market, By Region, 2016–2024 (USD Million)
Table 42 North America: Market, By Country, 2016–2024 (USD Million)
Table 43 North America: Market, By Product, 2016–2024 (USD Million)
Table 44 North America: Immunoprecipitation Reagents Market, By Type, 2016–2024 (USD Million)
Table 45 North America: Immunoprecipitation Antibodies Market, By Type, 2016–2024 (USD Million)
Table 46 North America: Immunoprecipitation Beads Market, By Type, 2016–2024 (USD Million)
Table 47 North America: Market, By Type, 2016–2024 (USD Million)
Table 48 North America: Market, By End User, 2016–2024 (USD Million)
Table 49 US: Market, By Product, 2016–2024 (USD Million)
Table 50 US: Immunoprecipitation Reagents Market, By Type, 2016–2024 (USD Million)
Table 51 US: Immunoprecipitation Antibodies Market, By Type, 2016–2024 (USD Million)
Table 52 US: Immunoprecipitation Beads Market, By Type, 2016–2024 (USD Million)
Table 53 US: Market, By Type, 2016–2024 (USD Million)
Table 54 US: Market, By End User, 2016–2024 (USD Million)
Table 55 Canada: Market, By Product, 2016–2024 (USD Million)
Table 56 Canada: Immunoprecipitation Reagents Market, By Type, 2016–2024 (USD Million)
Table 57 Canada: Immunoprecipitation Antibodies Market, By Type, 2016–2024 (USD Million)
Table 58 Canada: Immunoprecipitation Beads Market, By Type, 2016–2024 (USD Million)
Table 59 Canada: Market, By Type, 2016–2024 (USD Million)
Table 60 Canada: Market, By End User, 2016–2024 (USD Million)
Table 61 Europe: Market, By Product, 2016–2024 (USD Million)
Table 62 Europe: Immunoprecipitation Reagents Market, By Type, 2016–2024 (USD Million)
Table 63 Europe: Immunoprecipitation Antibodies Market, By Type, 2016–2024 (USD Million)
Table 64 Europe: Immunoprecipitation Beads Market, By Type, 2016–2024 (USD Million)
Table 65 Europe: Market, By Type, 2016–2024 (USD Million)
Table 66 Europe: Market, By End User, 2016–2024 (USD Million)
Table 67 Asia Pacific: Market, By Product, 2016–2024 (USD Million)
Table 68 Asia Pacific: Immunoprecipitation Reagents Market, By Type, 2016–2024 (USD Million)
Table 69 Asia Pacific: Immunoprecipitation Antibodies Market, By Type, 2016–2024 (USD Million)
Table 70 Asia Pacific: Immunoprecipitation Beads Market, By Type, 2016–2024 (USD Million)
Table 71 Asia Pacific: Market, By Type, 2016–2024 (USD Million)
Table 72 Asia Pacific: Market, By End User, 2016–2024 (USD Million)
Table 73 RoW: Market, By Product, 2016–2024 (USD Million)
Table 74 RoW: Immunoprecipitation Reagents Market, By Type, 2016–2024 (USD Million)
Table 75 RoW: Immunoprecipitation Antibodies Market, By Type, 2016–2024 (USD Million)
Table 76 RoW: Immunoprecipitation Beads Market, By Type, 2016–2024 (USD Million)
Table 77 RoW: Market, By Type, 2016–2024 (USD Million)
Table 78 RoW: Market, By End User, 2016–2024 (USD Million)
Table 79 Expansions, 2016–2018
Table 80 Collaborations, Partnerships, and Agreements, 2016–2018
Table 81 Product Launches, 2016–2018
Table 82 Acquisitions, 2016-2018

List of Figures

Figure 1 Immunoprecipitation Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designations, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market, By Product, 2018 vs 2024 (USD Million)
Figure 8 Market, By Type, 2018 vs 2024 (USD Million)
Figure 9 Market, By End User, 2018 vs 2024 (USD Million)
Figure 10 Geographical Snapshot of the Immunoprecipitation Market
Figure 11 Increasing Number of Research Activities in the Life Sciences Industry is A Key Driver for the Immunoprecipitation Market
Figure 12 Kits to Continue to Dominate the Immunoprecipitation Market in 2024
Figure 13 Individual Ip Accounted for the Largest Share of the North American Immunoprecipitation Market in 2018
Figure 14 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 15 Life Sciences R&D Spending, Global vs US (USD Billion)
Figure 16 North America: Market Snapshot
Figure 17 Asia Pacific: Market Snapshot
Figure 18 Immunoprecipitation Market (Global) Competitive Leadership Mapping, 2017
Figure 19 Rank of Companies in the Global Immunoprecipitation Market, 2017
Figure 20 Thermo Fisher Scientific: Company Snapshot
Figure 21 Abcam: Company Snapshot
Figure 22 Genscript: Company Snapshot
Figure 23 Merck KGaA: Company Snapshot
Figure 24 Bio-Rad Laboratories: Company Snapshot
Figure 25 Takara Bio: Company Snapshot

Samples

LOADING...

Executive Summary

Companies Mentioned

Abcam
Bio-Rad Laboratories
Biolegend
Cell Signaling Technology
Geno Technology
Genscript
Merck KGaA
Rockland Immunochemicals
Takara Bio
Thermo Fisher Scientific

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4787EUR$4,950USD£4,103GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6431EUR$6,650USD£5,511GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€7881EUR$8,150USD£6,755GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€9671EUR$10,000USD£8,288GBP

Immunoprecipitation Market by Product (Kit, Reagent (Antibodies, Magnetic Buffer)), Type (Individual IP, Coimmunoprecipitation, CHIP), End User (Academics, Research Institutes, Pharmaceutical and Biotechnology Companies) - Global Forecast to 2024

Table of Contents

Samples

Executive Summary

Companies Mentioned

Table of Contents

Samples

Executive Summary

Companies Mentioned

Related Topics

Related Reports

Global Immunoprecipitation Market by Product (Accessories, Beads, Kits), Type (Chromatin Immunoprecipitation, Co-Immunoprecipitation, Individual Immunoprecipitation), End-User - Forecast 2024-2030

Global Immunoprecipitation Market Analysis & Forecast to 2024-2034

Global Immunoprecipitation Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Chromatin immunoprecipitation (ChIP) Sequencing Global Market Report 2024

Immunoprecipitation - Global Strategic Business Report